Jeena Sikho Lifecare Reports Robust Q1 FY26 Growth and Successful Mainboard Migration
The strong financial performance demonstrates robust business growth and operational leverage, which are critical factors for investor confidence and potential stock price appreciation. The migration to the mainboard is a significant corporate action that can lead to increased liquidity, broader institutional investor participation, and improved valuation for the company.
The company reported substantial year-on-year and quarter-on-quarter growth in key financial metrics (revenue, EBITDA, PAT, EPS) and operational volumes. The significant expansion in EBITDA and PAT margins indicates improved profitability and efficiency. Additionally, the successful migration to the mainboard is a positive corporate development expected to enhance market visibility and investor access.
* Jeena Sikho Lifecare Limited announced a strong financial performance for Q1 FY2025-26, with Revenue from Operations reaching ₹174.29 crore, marking a significant 74% year-on-year (YoY) growth and 25% quarter-on-quarter (QoQ) growth. * Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) surged by 220% YoY to ₹78.79 crore, with EBITDA margins expanding to 45% in Q1 FY26, compared to 25% in Q1 FY25 and 34% in Q4 FY25. * Profit After Tax (PAT) increased by 218% YoY to ₹51.31 crore, and the PAT margin improved to 29% from 16% in Q1 FY25 and 20% in Q4 FY25. * Earnings Per Share (EPS) for Q1 FY26 stood at ₹4.13, reflecting a 218% YoY increase. * Operational highlights include significant growth in patient volumes: In-Patient Department (IPD) volumes grew 46% YoY to 8,616, Out-Patient Department (OPD) volumes rose 68% YoY to 1.24 lakh, and Day Care volumes increased by 164% YoY to 14,828. * The company added 391 new beds in Q1 FY26, bringing the total operational bed count to 2,179, with an additional 360 beds in the pipeline. * Managing Director Acharya Manish Ji commented on the strong all-round performance, highlighting broad-based revenue growth in both services and products, significant margin expansion, and successful footprint expansion. He also noted a strategic shift towards the more profitable Private Panchkarma segment. * Jeena Sikho Lifecare Limited successfully migrated to the mainboard of the National Stock Exchange (NSE) and BSE in August 2025 from the NSE Emerge platform. This move is expected to enhance the company's market visibility and access to a broader pool of investors. * The investor presentation will be used during meetings with investors scheduled for August 18, 2025.
What to do with a filing like this
Jeena Sikho Lifecare Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jeena Sikho Lifecare Limited. Read the original for the full detail.